NIH Launches First New HIV Vaccine Efficacy Study in 7 Years in South Africa
November 29th 2016The first HIV vaccine efficacy study in seven years is currently being conducted in South Africa, with researchers testing if a new vaccine regimen called HVTN 702 can provide adequate protection against HIV.
Could New Perinatal Hepatitis B Prevention Laws Save Infants from Premature Death?
November 25th 2016A recent study assessed if laws pertaining to the screening and reporting of hepatitis B may increase identification in pregnant women and thus, allow for more infants who have been exposed to the virus to receive post-exposure prophylaxis.
Novel Class of Drugs May Inhibit Antibiotic Resistance in Bacteria
November 25th 2016On their quest to put an end to a threat that may change modern medicine as we know it, researchers discovered four chemicals that disrupt AcrA, an efflux pump protein, that contributes to antibiotic resistance in bacteria.
Examining the Business of Infectious Diseases in the Time of Zika Virus
November 23rd 2016Most biotech and pharmaceutical companies focus their research efforts on cures for chronic diseases that plague the majority of the population because that’s where the money lies; however, is the rise in devastating infectious diseases such as Zika redirecting the lens of many companies?
Madison County Experiences Staggering 90% Increase in Syphilis Cases
November 22nd 2016The Alabama Department of Public Health has issued a health advisory in an attempt to increase awareness and prevention efforts in Madison County after seeing a dramatic increase in reported syphilis cases since last year.